¼¼°èÀÇ ¹æ»ç¼± Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Radiotherapy Global Market Report 2025
»óǰÄÚµå : 1720875
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,242,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,023,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,803,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹æ»ç¼± Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÃÖ¼Ò Ä§½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÁýÁß Áõ°¡, °¡Á¤ ±â¹Ý ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ǰÁú º¸Áõ ÇÁ·Î±×·¥ÀÇ Áß½ÃÀÇ °íÁ¶, ¾Ï ÀÇ·á¿¡ ÀÓÇÏ´Â ¼¼°è Çコ ÀÌ´Ï¼ÅÆ¼ºêÀÇ È®´ë µî¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä µ¿ÇâÀ¸·Î¼­´Â ¿µ»ó À¯µµ¿¡ ÀÇÇÑ ¹æ»ç¼± Ä¡·áÀÇ ¹ßÀü, ÀÔÀÚ¼± Ä¡·áÀÇ Áøº¸, »õ·Î¿î ºê·¢¼¼¶óÇÇ ±â¼úÀÇ °³¹ß, »çÀ̹ö ³ªÀÌÇÁ ±â¼úÀÇ Çõ½Å, Ä¡·á °èȹ¿¡ À־ÀÇ ÀΰøÁö´ÉÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

¾Ï ÀÌȯÀ²ÀÇ »ó½ÂÀÌ ¹æ»ç¼± Ä¡·á ½ÃÀåÀÇ È®´ë¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ¾Ï ¹ß»ý·üÀÇ Áõ°¡´Â Àα¸ÀÇ °í·ÉÈ­, ½Ä»ýȰÀÇ È¥¶õÀ̳ª ¿îµ¿ ºÎÁ·À» Æ÷ÇÔÇÑ ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­, ´ã¹è³ª ¾ËÄÚ¿ÃÀÇ ´Ù·® ¼·Ãë, ȯ°æ ¿À¿°, Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Áø´Ü ÅøÀÇ Áøº¸ µîÀÇ ¿äÀΰú °ü·ÃµÇ¾î ÀÖ½À´Ï´Ù. ¹æ»ç¼± Ä¡·á´Â ¾Ï¼¼Æ÷¸¦ Á¤È®ÇÏ°Ô Ç¥ÀûÀ¸·Î ÆÄ±«Çϰí Á¾¾çÀ» ÀÛ°Ô ÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÔÀ¸·Î½á ¾Ï Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 8¿ù ¿µ±¹ ¾Ï ȯÀÚ Áö¿ø ÀÚ¼± ´ÜüÀÎ ¸Æ¹Ð¶õ ¾Ï Áö¿ø(Macmillan Cancer Support)Àº ¿µ±¹¿¡¼­ 300¸¸ ¸í ÀÌ»óÀÌ ¾ÏÀ» ¾È°í »ì¾Æ°¡°í ÀÖÀ¸¸ç 2025³â±îÁö 350¸¸¸í, 2030³â±îÁö 400¸¸¸í, 2040³â±îÁö 530¸¸¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

¹æ»ç¼± Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº À̹ÌÁö À¯µµ ¹æ»ç¼± Ä¡·á(IGRT)¿Í °°Àº Çõ½ÅÀûÀÎ ±â¼ú °³¹ßÀ» ¼±È£Çϰí, Ä¡·áÀÇ Á¤È®¼ºÀ» ³ôÀ̰í, ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϸç, ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. Á¾¾ç Ÿ°ÙÆÃÀ» º¸ÀåÇϱâ À§ÇØ °í±Þ À̹ÌÁö µµ±¸¸¦ »ç¿ëÇÏ¿© Á¤È®¼ºÀ» ³ôÀ̱â À§ÇØ Á¾¾çÀÇ À§Ä¡¸¦ ½Ç½Ã°£À¸·Î ÃßÀûÇϰí Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. 2022³â 5¿ù ½º¿þµ§¿¡ º»»ç¸¦ µÐ ÀÇ·á ±â¼ú ȸ»çÀÎ Elekta AB´Â Á¤À§ ¹æ»ç¼± ¼ö¼úÀÇ ±â´ÉÀ» °­È­ÇÏ´Â Â÷¼¼´ë ¹æ»ç¼± ¼ö¼ú ½Ã½ºÅÛÀÎ Elekta EspritÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¿©·¯ Çõ½Å ±â¼úÀ» ´ÜÀÏ Ç÷§Æû¿¡ ÅëÇÕÇÏ¿© Ä¡·á ÆÀ¿¡ ¶Ù¾î³­ ½Ã°¢È­ ¹× ¿ø°Ý ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Radiotherapy is a medical treatment that utilizes high doses of radiation to destroy cancer cells and shrink tumors. It is commonly used to treat various types of cancer, either as a standalone therapy or in combination with surgery and chemotherapy.

The primary types of radiotherapy include external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy delivers high-energy radiation from an external machine to target and destroy cancer cells. This treatment is applied to various cancers, including prostate, breast, lung, head and neck, colorectal, gynecological, cervical, and penile cancers, among others. It is used by multiple end users, such as hospitals and diagnostic labs, cancer treatment and research centers, academic institutions, and ambulatory surgery centers.

The radiotherapy market research report is one of a series of new reports from The Business Research Company that provides radiotherapy market statistics, including the radiotherapy industry's global market size, regional shares, competitors with a radiotherapy market share, detailed radiotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy industry. This radiotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiotherapy market size has grown strongly in recent years. It will grow from $7.38 billion in 2024 to $7.92 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period was driven by the increasing incidence of cancer cases worldwide, rising demand for non-invasive cancer treatments, expansion of healthcare infrastructure, greater adoption of personalized medicine, and a growing patient population requiring cancer treatment.

The radiotherapy market size is expected to see strong growth in the next few years. It will grow to $10.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period is expected to be driven by increasing investment in advanced healthcare technologies, a growing focus on minimally invasive treatment options, rising demand for home-based healthcare solutions, an increasing emphasis on quality assurance programs, and expanding global health initiatives addressing cancer care. Key trends include advancements in image-guided radiotherapy, progress in particle therapy, the development of novel brachytherapy techniques, innovations in CyberKnife technology, and the integration of artificial intelligence in treatment planning.

The rising prevalence of cancer is anticipated to drive the expansion of the radiotherapy market. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body, affecting various tissues and organs and leading to a wide range of symptoms. The increasing incidence of cancer is linked to factors such as an aging population, lifestyle changes including poor diet and physical inactivity, high tobacco and alcohol consumption, environmental pollution, and advancements in diagnostic tools that enable earlier detection. Radiotherapy plays a vital role in cancer treatment by precisely targeting and destroying cancerous cells, reducing tumor size, and improving patient outcomes. For example, in August 2024, Macmillan Cancer Support, a UK-based charitable organization supporting cancer patients, reported that more than 3 million people in the UK were living with cancer, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising prevalence of cancer is fueling the growth of the radiotherapy market.

Leading companies in the radiotherapy market are prioritizing the development of innovative technologies, such as image-guided radiotherapy (IGRT), to enhance treatment precision, improve patient outcomes, and minimize damage to surrounding healthy tissues. IGRT utilizes advanced imaging tools to ensure accurate tumor targeting during radiation therapy, allowing real-time tracking and adjustments to the tumor's position for increased precision. For instance, in May 2022, Elekta AB, a Sweden-based medical technology company, introduced the Elekta Esprit, a next-generation radiosurgery system that enhances the capabilities of stereotactic radiosurgery. This system integrates multiple innovations into a single platform, offering superior visualization and remote accessibility for treatment teams. It supports flexible workflow options, including single-session, fractionated, adaptive, or staged protocols, optimizing ease of use and efficiency in clinical settings. With an accuracy of less than 0.3 mm, the system is designed to treat even the most challenging targets while preserving surrounding healthy tissues.

In February 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired RayzeBio Inc. for an undisclosed amount. This acquisition strengthens its oncology pipeline with advanced radiopharmaceutical therapeutics, including RYZ101, which targets SSTR2 in GEP-NETs and ES-SCLC. With ongoing clinical trials and a state-of-the-art manufacturing facility, this strategic move enables Bristol Myers Squibb to accelerate innovation, expand treatment options, and drive growth in the oncology sector. RayzeBio Inc. is a US-based company specializing in the development of innovative radiopharmaceuticals for cancer treatment.

Major players in the radiotherapy market are Hitachi Ltd., Koninklijke Philips N.V., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.

North America was the largest region in the radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotherapy market includes revenues earned by entities by providing services such as brachytherapy, palliative radiotherapy, proton therapy, and intraoperative radiotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiotherapy market consists of sales of patient positioning systems, surface-guided radiation therapy systems (SGRT), CT and MRI simulation systems, and linear accelerators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for radiotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Radiotherapy Market Characteristics

3. Radiotherapy Market Trends And Strategies

4. Radiotherapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Radiotherapy Growth Analysis And Strategic Analysis Framework

6. Radiotherapy Market Segmentation

7. Radiotherapy Market Regional And Country Analysis

8. Asia-Pacific Radiotherapy Market

9. China Radiotherapy Market

10. India Radiotherapy Market

11. Japan Radiotherapy Market

12. Australia Radiotherapy Market

13. Indonesia Radiotherapy Market

14. South Korea Radiotherapy Market

15. Western Europe Radiotherapy Market

16. UK Radiotherapy Market

17. Germany Radiotherapy Market

18. France Radiotherapy Market

19. Italy Radiotherapy Market

20. Spain Radiotherapy Market

21. Eastern Europe Radiotherapy Market

22. Russia Radiotherapy Market

23. North America Radiotherapy Market

24. USA Radiotherapy Market

25. Canada Radiotherapy Market

26. South America Radiotherapy Market

27. Brazil Radiotherapy Market

28. Middle East Radiotherapy Market

29. Africa Radiotherapy Market

30. Radiotherapy Market Competitive Landscape And Company Profiles

31. Radiotherapy Market Other Major And Innovative Companies

32. Global Radiotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotherapy Market

34. Recent Developments In The Radiotherapy Market

35. Radiotherapy Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â